Related Experiment Videos
Percutaneous excimer laser coronary angioplasty
F Litvack1, N L Eigler, J R Margolis
1Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048.
The American Journal of Cardiology
|November 1, 1990
Summary
Percutaneous excimer laser coronary angioplasty safely ablates plaque and reduces coronary stenoses. This laser technique showed an 84% acute success rate in a multicenter trial.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Coronary artery disease remains a leading cause of mortality worldwide.
- Conventional balloon angioplasty is effective but has limitations in certain lesion types.
- Novel percutaneous coronary intervention techniques are needed to improve outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous excimer laser coronary angioplasty (PECLA) as an adjunct or alternative to balloon angioplasty.
- To assess the impact of PECLA on coronary stenosis reduction and lumen diameter.
- To determine the acute success rate and complication profile of PECLA.
Main Methods:
- A multicenter trial involving 55 patients with coronary stenoses.
- Utilized a first-generation excimer laser catheter (1.6-mm diameter) with energy densities of 35-50 mJ/mm2.
- Acute success defined as >=20% increase in stenotic diameter and lumen diameter >=1 mm post-procedure.
Main Results:
- Acute success was achieved in 46 of 55 patients (84%).
- Mean diameter stenosis decreased from 83% to 49% after laser treatment, and to 38% with adjunctive balloon angioplasty.
- Mean minimal stenotic diameter increased from 0.5 mm to 1.6 mm post-laser and 2.1 mm post-balloon angioplasty.
Conclusions:
- Percutaneous excimer laser angioplasty safely ablates atheroma and effectively reduces coronary stenoses.
- PECLA demonstrates a high acute success rate and a favorable safety profile.
- This laser-based approach offers a promising alternative or adjunct to conventional balloon angioplasty for coronary interventions.